University of Michigan Addiction Treatment Servs (UMATS)
-
Services:
- Sign language services for the deaf and hard of hearing
- Private non-profit organization
- Adolescents
- Clients with co-occurring mental and substance use disorders
- Adult men
- Clients who have experienced trauma
- Young adults
- Clients with co-occurring pain and substance use disorders
- Self-help groups
- Mentoring/peer support
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Methamphetamines detoxification
- Medication routinely used during detoxification
- Cocaine Detoxification
- Opioids detoxification
- Social skills development
- Suicide prevention services
- Mental health services
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Vaping not permitted
- Discharge Planning
- Aftercare/continuing care
- Naloxone and overdose education
- Male
- Female
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- No formal relationship with prescribing entity
- In-network prescribing entity
- Other contracted prescribing entity
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Smoking not permitted
- Outpatient detoxification
- Outpatient methadone/buprenorphine or naltrexone treatment
- Intensive outpatient treatment
- Regular outpatient treatment
- Outpatient
- Telemedicine/telehealth therapy
- Relapse prevention
- Brief intervention
- Motivational interviewing
- Anger management
- Substance use disorder counseling
- Trauma-related counseling
- Cognitive behavioral therapy
- 12-step facilitation
- Maintenance service with medically supervised withdrawal after stabilization
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Buprenorphine maintenance
- Relapse prevention with naltrexone
- Buprenorphine detoxification
- Prescribes naltrexone
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Substance use treatment
- Family counseling
- Health education services other than HIV/AIDS or hepatitis
- Substance use disorder education
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Hepatitis education, counseling, or support
- In-network prescribing entity
- No formal relationship with prescribing entity
- The Joint Commission
- State mental health department
- Buprenorphine (extended-release, injectable)
- Buprenorphine without naloxone
- Acamprosate (Campral®)
- Naltrexone (oral)
- Clonidine
- Disulfiram
- Nicotine replacement
- Medication for mental disorders
- Buprenorphine with naloxone
- Non-nicotine smoking/tobacco cessation
- Naltrexone (extended-release, injectable)
- Interim services for clients
- Outreach to persons in the community
- Comprehensive substance use assessment
- Screening for mental disorders
- Complete medical history/physical exam
- Comprehensive mental health assessment
- Screening for tobacco use
- Screening for substance use
- Medicare
- State-financed health insurance plan other than Medicaid
- Cash or self-payment
- Private health insurance
Language Services
Facility Operation (e.g., Private, Public)
Special Programs/Groups Offered
Recovery Support Services
Detoxification (medical withdrawal) Services
Ancillary Services
Opioid Medications used in Treatment
Facility Vaping Policy
Transitional Services
Gender Accepted
Type of Alcohol Use Disorder Treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Testing
Facility Smoking Policy
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Treatment Approaches
Type of Opioid Treatment
Type of Care
Education and Counseling Services
External Opioid Medications Source
License/Certification/Accreditation
Pharmacotherapies
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted